Cochlear Financials
| CHEOF Stock | USD 175.01 6.34 3.76% |
Cochlear |
Understanding current and past Cochlear Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cochlear's financial statements are interrelated, with each one affecting the others. For example, an increase in Cochlear's assets may result in an increase in income on the income statement.
Cochlear Stock Summary
Cochlear competes with Eurofins Scientific, Alibaba Health, Sonova Holding, Sonova Holding, and Demant AS. Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear Ord operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4500 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 1 University Avenue, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.cochlear.com |
| Phone | 61 2 9428 6555 |
| Currency | USD - US Dollar |
Cochlear Key Financial Ratios
There are many critical financial ratios that Cochlear's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cochlear Limited reports annually and quarterly.| Return On Equity | 0.17 | |||
| Return On Asset | 0.0973 | |||
| Beta | 0.43 | |||
| Z Score | 22.8 | |||
| Last Dividend Paid | 3.0 |
Cochlear Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cochlear's current stock value. Our valuation model uses many indicators to compare Cochlear value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cochlear competition to find correlations between indicators driving Cochlear's intrinsic value. More Info.Cochlear Limited is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Cochlear Limited is roughly 1.76 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cochlear's earnings, one of the primary drivers of an investment's value.Cochlear Limited Systematic Risk
Cochlear's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cochlear volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Cochlear Limited correlated with the market. If Beta is less than 0 Cochlear generally moves in the opposite direction as compared to the market. If Cochlear Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cochlear Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cochlear is generally in the same direction as the market. If Beta > 1 Cochlear moves generally in the same direction as, but more than the movement of the benchmark.
Cochlear December 29, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cochlear help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cochlear Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cochlear Limited based on widely used predictive technical indicators. In general, we focus on analyzing Cochlear Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cochlear's daily price indicators and compare them against related drivers.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 18.12 | |||
| Value At Risk | (5.73) | |||
| Potential Upside | 3.76 |
Complementary Tools for Cochlear Pink Sheet analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |